Next Financial Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $423K | Buy |
4,968
+1,341
| +37% | +$114K | 0.03% | 617 |
|
|
2021
Q3 | $348K | Buy |
3,627
+713
| +24% | +$68.4K | 0.03% | 604 |
|
|
2021
Q2 | $284K | Sell |
2,914
-310
| -10% | -$30.2K | 0.02% | 705 |
|
|
2021
Q1 | $314K | Buy |
3,224
+208
| +7% | +$20.3K | 0.03% | 612 |
|
|
2020
Q4 | $289K | Buy |
3,016
+860
| +40% | +$82.4K | 0.03% | 576 |
|
|
2020
Q3 | $208K | Buy |
+2,156
| New | +$208K | 0.02% | 603 |
|
|
2020
Q2 | – | Sell |
-630
| Closed | -$55K | – | 1423 |
|
|
2020
Q1 | $55K | Hold |
630
| – | – | 0.01% | 961 |
|
|
2019
Q4 | $68K | Buy |
630
+70
| +13% | +$7.56K | 0.01% | 1081 |
|
|
2019
Q3 | $50K | Hold |
560
| – | – | 0.01% | 1148 |
|
|
2019
Q2 | $47K | Buy |
560
+265
| +90% | +$22.2K | 0.01% | 1188 |
|
|
2019
Q1 | $26K | Hold |
295
| – | – | 0.01% | 896 |
|
|
2018
Q4 | $21K | Sell |
295
-100
| -25% | -$7.12K | ﹤0.01% | 1075 |
|
|
2018
Q3 | $49K | Buy |
+395
| New | +$49K | 0.02% | 553 |
|
|
2017
Q4 | – | Sell |
-275
| Closed | -$17K | – | 983 |
|
|
2017
Q3 | $17K | Buy |
275
+175
| +175% | +$10.8K | ﹤0.01% | 1027 |
|
|
2017
Q2 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 1547 |
|
|
2017
Q1 | – | Sell |
-230
| Closed | -$9K | – | 2134 |
|
|
2016
Q4 | $9K | Hold |
230
| – | – | ﹤0.01% | 1698 |
|
|
2016
Q3 | $12K | Buy |
+230
| New | +$12K | ﹤0.01% | 1588 |
|
|
2014
Q4 | – | Sell |
-430
| Closed | -$7K | – | 2181 |
|
|
2014
Q3 | $7K | Buy |
+430
| New | +$7K | ﹤0.01% | 1935 |
|